ArticleMolecular psychiatry2026
Machine learning reveals a multimodal, transdiagnostic signature of emotion dysregulation vulnerability across patients, offspring, and controls.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emotion dysregulation (ED) is a core transdiagnostic feature of several psychiatric disorders, including borderline personality disorder, bipolar disorder, and attention-deficit/hyperactivity disorder. These ED disorders (EDD) exhibit overlapping clinical presentations, shared heritability, and common neurobiological substrates. This study used a transdiagnostic framework to identify early and multimodal markers of vulnerability, particularly in high-risk populations such as the offspring of EDD patients (EDDoff). A total of 237 participants (97 EDD patients, 67 EDDoff, 73 healthy controls; 139 females in total) completed a multimodal assessment including clinical evaluations, diffusion and functional MRI, and immune and neurotrophic serum biomarkers. Dimensionality reduction was performed using principal component analysis (PCA), and exploratory random forest (RF) models were trained for group classification and symptoms prediction. PCA on the full multimodal dataset yielded eight components, two of which significantly differed between groups, one reflecting high ED and altered hippocampal dynamic functional connectivity (dFC), for which EDDoff showed an intermediate phenotype, and another driven by systemic inflammation, increased in EDD patients only. Modality-specific PCA identified significant inter-modality correlations, including reduced white matter integrity with increasing immune dysregulation, and positive correlations between hippocampal dFC and both ED symptoms and inflammation (p
Identifiers
42509313What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.